| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.10. | Lonza Expands Cell and Gene Therapy Portfolio | ||
| 06.10. | FDA Lifts Clinical Hold on NUZ-001 | ||
| 06.10. | Mytos Launches Automated CDMO Offering | ||
| 06.10. | Halia Therapeutics Appoints Paul Jones as Chief Strategy Officer | ||
| 03.10. | FDA Approves Roche's Tecentriq with Lurbinectedin for ES-SCLC | ||
| 03.10. | Alto Neuroscience's Schizophrenia Treatment Granted FDA Fast Track Designation | ||
| 02.10. | START and Minerva Imaging Expand Radiopharmaceutical Development Alliance | ||
| 02.10. | Celltrion Launches Avtozma IV Formulation in the U.S. | ||
| 02.10. | Pfizer Reaches Pricing Agreement With Trump Administration | ||
| 01.10. | Wheeler Bio Taps Jay Benson as COO | ||
| 01.10. | Klotho Neurosciences to Acquire Longevity Therapeutic Assets from Turn Biotechnologies | ||
| 01.10. | Bionique Testing Laboratories Completes Expansion | ||
| 01.10. | Primrose Bio Appoints Drew Burch CEO | ||
| 01.10. | Symeres Names Gabriella Gentile as COO | ||
| 01.10. | Halozyme Therapeutics to Acquire Elektrofi | ||
| 01.10. | Cryoport Adds New Global Supply Chain Center in Louvres, France | ||
| 30.09. | GSK Names Luke Miels as Next Chief Executive Officer | ||
| 30.09. | Nelson Laboratories Launches RapidCert | ||
| 30.09. | Orexo US Awarded $8M in Funding by BARDA | ||
| 30.09. | Sharp Services Taps Samantha Wilson Jones as General Counsel & Corporate Secretary | ||
| 30.09. | Symbiosis Completes Qualification of New FDP 50 Flexicon Automated Fill/Finish Line | ||
| 30.09. | GeneDx Appoints Lisa Gurry as Chief Business Officer | ||
| 30.09. | Labcorp Partners with Roche to Integrate Digital Slide Scanning | ||
| 29.09. | AbbVie Breaks Ground on Chicago API Manufacturing Plant | ||
| 29.09. | Contract Pharma Welcomes Julie Fuhrer as New Publisher |